{"id":"triptorelin-0-1","safety":{"commonSideEffects":[{"rate":"60-80","effect":"Hot flashes"},{"rate":"10-20","effect":"Injection site reactions"},{"rate":"5-15","effect":"Headache"},{"rate":"10-20","effect":"Fatigue"},{"rate":"20-40","effect":"Decreased libido"},{"rate":"20-40","effect":"Erectile dysfunction"},{"rate":"5-10","effect":"Gynecomastia"},{"rate":null,"effect":"Bone density loss"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Triptorelin binds to GnRH receptors in the pituitary gland, initially causing a surge in gonadotropin release followed by sustained suppression of LH and FSH through receptor desensitization. This results in profound suppression of testosterone in males and estrogen in females, making it useful for hormone-dependent conditions and reproductive applications.","oneSentence":"Triptorelin is a gonadotropin-releasing hormone (GnRH) agonist that suppresses luteinizing hormone and follicle-stimulating hormone, leading to decreased sex hormone production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:39:12.697Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer (advanced)"},{"name":"Breast cancer (hormone-receptor positive)"},{"name":"Endometriosis"},{"name":"Uterine fibroids"},{"name":"Precocious puberty"},{"name":"Fertility preservation and assisted reproduction"}]},"trialDetails":[{"nctId":"NCT05286554","phase":"PHASE4","title":"Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-03-17","conditions":"Female Infertility","enrollment":75},{"nctId":"NCT06691815","phase":"NA","title":"Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism","status":"ENROLLING_BY_INVITATION","sponsor":"Hospital de Niños R. Gutierrez de Buenos Aires","startDate":"2022-08-01","conditions":"Pubertal Delay, Hypogonadism, Hypogonadotropic, Constitutional Delay in Growth and Puberty (CDGP)","enrollment":48},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT05567731","phase":"NA","title":"Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-15","conditions":"Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility","enrollment":30},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT05972902","phase":"PHASE3","title":"Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-15","conditions":"IVF","enrollment":387},{"nctId":"NCT05969834","phase":"","title":"HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2021-03-31","conditions":"Infertility","enrollment":100},{"nctId":"NCT04600986","phase":"NA","title":"Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2020-05-30","conditions":"Polycystic Ovary Syndrome","enrollment":70},{"nctId":"NCT03940807","phase":"PHASE3","title":"Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis","status":"WITHDRAWN","sponsor":"University Hospital, Toulouse","startDate":"2022-04-29","conditions":"Adenomyosis","enrollment":""},{"nctId":"NCT03660813","phase":"NA","title":"Follicle Size and Oocyte Development","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2018-07-01","conditions":"IVF Treatment","enrollment":200},{"nctId":"NCT05397795","phase":"PHASE3","title":"COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2022-06-01","conditions":"Infertility","enrollment":160},{"nctId":"NCT04087408","phase":"PHASE3","title":"Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Moustafa Mohammed Abouelea","startDate":"2020-04-01","conditions":"Effect of Adding GnRHa as Luteal Phase Support in Antagonist ART Cycles","enrollment":150},{"nctId":"NCT05321511","phase":"PHASE4","title":"Comparison of Triggers in Double Ovarian Stimulation (DuoStim).","status":"UNKNOWN","sponsor":"Instituto Bernabeu","startDate":"2022-03-03","conditions":"IVF, LOW OVARIAN RESPONSE","enrollment":165},{"nctId":"NCT00725491","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-05","conditions":"Controlled Ovarian Stimulation","enrollment":259},{"nctId":"NCT05112692","phase":"NA","title":"Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-11","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":200},{"nctId":"NCT01278290","phase":"PHASE3","title":"Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls","status":"COMPLETED","sponsor":"Hospital de Niños R. Gutierrez de Buenos Aires","startDate":"2009-12","conditions":"Central Precocious Puberty, Sexual Precocity","enrollment":46},{"nctId":"NCT03784404","phase":"PHASE4","title":"Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-12","conditions":"Ovarian Endometrioma","enrollment":100},{"nctId":"NCT02381821","phase":"","title":"Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-01-01","conditions":"Reproductive Techniques, Assisted","enrollment":82},{"nctId":"NCT02338206","phase":"PHASE2","title":"Long Protocol and Growth Hormone in Poor Responders","status":"COMPLETED","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2015-03","conditions":"Infertility","enrollment":240},{"nctId":"NCT03118830","phase":"PHASE4","title":"Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-04-21","conditions":"Invitro Fertilization","enrollment":204},{"nctId":"NCT02741154","phase":"PHASE4","title":"Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI","status":"COMPLETED","sponsor":"Minia University","startDate":"2016-08-12","conditions":"Infertility Indicated for ICSI","enrollment":50},{"nctId":"NCT02053779","phase":"PHASE3","title":"GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Ibn Rochd","startDate":"2014-03","conditions":"Infertility","enrollment":328},{"nctId":"NCT03039049","phase":"PHASE3","title":"GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Ibn Rochd","startDate":"2014-03","conditions":"Infertility","enrollment":328},{"nctId":"NCT02208986","phase":"NA","title":"GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study","status":"COMPLETED","sponsor":"Vietnam National University","startDate":"2014-08","conditions":"Normal Oocyte Donors","enrollment":165},{"nctId":"NCT02825290","phase":"PHASE4","title":"Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2016-07","conditions":"Embryo Transfer, Luteal Support","enrollment":62},{"nctId":"NCT02620124","phase":"PHASE4","title":"GnRH Agonist as Luteal Support in FET Cycles","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2013-05","conditions":"Infertility","enrollment":100},{"nctId":"NCT01590173","phase":"PHASE2, PHASE3","title":"Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2012-01","conditions":"Infertility","enrollment":86},{"nctId":"NCT02827656","phase":"NA","title":"Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2016-08","conditions":"Infertility","enrollment":50},{"nctId":"NCT01798862","phase":"PHASE2, PHASE3","title":"Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2013-03","conditions":"Repeated Implantation Failures","enrollment":100},{"nctId":"NCT01973842","phase":"PHASE2","title":"Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients","status":"UNKNOWN","sponsor":"Aristotle University Of Thessaloniki","startDate":"2014-02","conditions":"Subfertility","enrollment":90},{"nctId":"NCT02674178","phase":"PHASE4","title":"FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2012-06","conditions":"Invitro Fertilization","enrollment":235},{"nctId":"NCT02655146","phase":"PHASE4","title":"the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .","status":"UNKNOWN","sponsor":"Chong Qing Reproducive and Genetic Institute","startDate":"2015-12","conditions":"Infertility","enrollment":700},{"nctId":"NCT01897324","phase":"PHASE4","title":"IVF/ICSI Protocols in Poor Responders With Growth Hormone","status":"COMPLETED","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2013-07","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":287},{"nctId":"NCT02442895","phase":"","title":"Biomarkers of Ovarian Reserve and Correlation With IVF Treatments","status":"COMPLETED","sponsor":"U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti","startDate":"2014-02","conditions":"Pregnancy, Ovarian","enrollment":236},{"nctId":"NCT01732094","phase":"PHASE2","title":"Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2012-07","conditions":"Infertility, Poor Ovarian Response","enrollment":57},{"nctId":"NCT01732068","phase":"PHASE2","title":"Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2012-07","conditions":"Infertility, Poor Ovarian Response","enrollment":51},{"nctId":"NCT01468441","phase":"NA","title":"Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days","status":"COMPLETED","sponsor":"Fertility - Assisted Fertilization Center","startDate":"2011-09","conditions":"Infertility","enrollment":96},{"nctId":"NCT01389713","phase":"NA","title":"Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve","status":"COMPLETED","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2008-09","conditions":"Infertility","enrollment":289},{"nctId":"NCT01007851","phase":"PHASE3","title":"Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles","status":"TERMINATED","sponsor":"V.K.V. American Hospital, Istanbul","startDate":"2006-09","conditions":"Infertility","enrollment":""},{"nctId":"NCT00985062","phase":"NA","title":"Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2004-10","conditions":"Subfertility","enrollment":54},{"nctId":"NCT00635258","phase":"","title":"Administration of GnRH Antagonist to Oocyte Donation Recipients","status":"COMPLETED","sponsor":"Centro Ginecologia y Obstetricia.","startDate":"2004-01","conditions":"Pregnancy, Embryo Implantation","enrollment":100},{"nctId":"NCT00542126","phase":"NA","title":"Luteal-Phase GnRH Agonist Administration in Frozen-Thawed IVF Embryo Transfer Cycles","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2007-12","conditions":"Pregnancy Rate","enrollment":""},{"nctId":"NCT00516490","phase":"NA","title":"GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles","status":"COMPLETED","sponsor":"V.K.V. American Hospital, Istanbul","startDate":"2006-09","conditions":"Infertility","enrollment":570},{"nctId":"NCT00417183","phase":"PHASE4","title":"Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation","status":"UNKNOWN","sponsor":"Eugonia","startDate":"2005-09","conditions":"Infertility","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":18,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["decapeptyl 0.1"],"phase":"marketed","status":"active","brandName":"triptorelin 0.1","genericName":"triptorelin 0.1","companyName":"Chong Qing Reproducive and Genetic Institute","companyId":"chong-qing-reproducive-and-genetic-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Triptorelin is a gonadotropin-releasing hormone (GnRH) agonist that suppresses luteinizing hormone and follicle-stimulating hormone, leading to decreased sex hormone production. Used for Prostate cancer (advanced), Breast cancer (hormone-receptor positive), Endometriosis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}